Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

More pregabalin strengths get concessionary prices

The Department of Health (DH) and National Assembly for Wales have agreed concessionary prices for further strengths of pregabalin.

Following the announcement on Tuesday (August 22) that further concessionary prices for pregabalin had been agreed, there are now updated prices for 225mg and 300mg strengths of the drug.

C+D reported last week that the DH had granted concessionary prices for packs of 84 50mg pregabalin capsules and 56 150mg capsules, which the Pharmaceutical Services Negotiating Committee (PSNC) said followed “hundreds” of reports from contractors about disproportionate pricing.

Pregabalin entered category M in August, a month after it came off patent for the treatment of neuropathic pain.

Pregabalin prices in the drug tariff currently range from £1.87 for a pack of 56 25mg capsules to £4.17 for a pack of 56 300mg capsules. But contractors told C+D earlier this month they are being forced to pay almost £20 per pack by wholesalers.

The latest concessionary prices are below, with initial concessionary prices for the month announced on August 11 and August 22.

Drug
Strength
Form
Price
Anastrozole
1mg
tablets (28)
£14.99
Pregabalin
225mg
capsules (56)
£13.75
Pregabalin
300mg
capsules (56)
£14.00

Have you been affected by pregabalin pricing and supply issues?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD008911

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel